Latest Rights Issue News

Carbine Resources secures a pivotal mining lease for its Muchea West Silica Sand Project and raises $1.78 million to fuel exploration, marking significant progress in its Australian silica sand ventures.

Alma Metals has bolstered its Briggs Copper JV Project with a $1.06 million capital raise and an updated resource estimate that now includes silver. The company is progressing a scoping study and preparing for significant drilling to unlock further value.

TechGen Metals Limited has announced a fully underwritten $2.57 million rights issue to accelerate exploration and drilling at its Blue Devil and Mt Boggola copper-gold projects in Western Australia.

The Calmer Co. International Limited reported a 6% quarterly revenue increase to $1.9 million in Q4 FY25, driving FY25 revenue to $8.0 million, an 86% year-on-year growth. Key channel expansions and cost efficiencies underpin its progress towards breakeven.

BauMart Holdings reports progress in AI-enhanced international recruitment, sustainable building materials development, and expansion into off-grid energy solutions, alongside a partial rights issue raising $180,000.

Bass Oil reported steady oil production and a significant cash reserve increase in the June quarter, while strategically acquiring the Vanessa gas field to pivot towards gas production.

Future Metals NL has raised A$4.2 million and entered a strategic MOU with Zeta Resources to explore processing its Eileen Bore and Panton ores at the Savannah Mine plant, signalling a new phase of development amid rising PGM prices.

HITIQ Ltd has launched its PROTEQT smart mouthguard for grassroots sports, secured a five-year exclusive global partnership with Shock Doctor, and raised $1.9 million to fund manufacturing and market growth.

Rent.com.au has reported its strongest half-year revenue to date, driven by robust growth in its RentBond and RentPay platforms, alongside launching self-funded RentBond loans backed by a $10 million debt facility.

Kore Potash has issued 500 CHESS Depositary Interests (CDIs) at AUD 0.0543 each, with shares set to commence trading on AIM, JSE, and ASX from 1 August 2025. This move finalizes a cleansing prospectus process and updates the company’s total voting rights.

Biotron Limited has successfully raised $1.27 million through an entitlement issue to fund its antiviral drug development, including a promising Hepatitis B compound that cleared its initial animal safety study.

Zoono Group Limited reports strong progress in its shelf-life extension technology with 45 active trials worldwide and anticipates UK revenue by Q2 FY26 following successful supermarket partnerships.